维普期刊资源整合服务平台（V6.5）

23篇 您的检索式：作者名="Patterson LH"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1 B1 显示文摘	POTTER GA PATTERSON LH WANOGHOL E	2002	Br J Cancer2002，86，5：	1
2	Tumour cytochrome P450 and drug activation显示文摘	Patterson LH Murray GI	2002	Curr Pharm Des2002，8，：	1
3	AQ4N:a new approach to hypoxia-activated cancer therapy显示文摘	MCKEOWN SR	2000	Br J of Cancer2000，8315，：	1
4	Enhancement of chemotherapy and radiotheraopy of murine tumours by AQ4N,a bioreductively activated anti-tumour agent显示文摘	MCKEOWN SR RUPARELIA K	2000	British Journal of Cancer2000，82，12：	1
5	The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by cytochrome P450 enzyme CYP1B1 显示文摘	Potter GA Patterson LH Wanogho E	2002	Br J Cancer2002，86，：	1
6	The cancer preventative agent resvemtrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1显示文摘	Potter GA Patterson LH Wanogho E	2002	Br J Cancer2002，86，5：	1
7	Tumor cytochrome P450 and drug activation显示文摘	Patterson LH Murray G1	2002	Curr Pharm Des2002，8，：	1
8	Function and antagonism of beta3 integrins in the development of cancer therapy显示文摘	Sheldrake HM Patterson LH	2009	Curr Cancer Drug Targets2009，9，4：	1
9	Tumour cytochrome P450 and drug acti-vation显示文摘	Patterson LH Murray GI	2002	Curr Pharm Des2002，8，15：	1
10	DNA mismatch repair deficiency,resistance to cancer chemotherapy and the development of hypersensitive agents显示文摘	Patterson LH	2005	Curr Top Med Chem2005，5，12：	1
11	DNA mismatch repair deficiency, resistance to cancer chemotherapy and the development of hypersensitive agents显示文摘	Pors K Patterson LH	2005	Curr Top Med Chem2005，5，12：	1
12	Rationale for the use of aliphatic N-oxides of cytotoxic anthraquinones as prodrug DNA binding agents: a new class of, bioreductive agent 显示文摘	Patterson LH	1993	Cancer Metastasis Rev1993，12，2：	1
13	Tumour cytochrome P450 and drug activation显示文摘	Patterson LH Murray GI	2002	Curr Pharm Des2002，8，15：	1
14	Tumour cytoehrome P450 and drug activa- tion 显示文摘	Patterson LH Murray GI	2002	Curr Pharm Des2002，8，15：	1
15	Involvement of hy- droxyl radical formation and DNA strand breakage in the cytotoxicity of anthraquinone antitumour agents 显示文摘	Fisher GR Brown JR Patterson LH	1990	Free Radic Res Commun1990，11，123：	1
16	The cancer preventative a- gent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1 B1 显示文摘	Potter GA Patterson LH Wanogho E	2002	Br J Cancer2002，86，5：	1
17	Tumour cytochrome P450 and drug activation显示文摘	Patterson LH Murray GL	2002	Curr Pharm Des2002，8，15：	1
18	Evaluation of a peer consultation program for burn inpatients显示文摘	Williams RM Patterson DR Schwenn C Day J Bartman M Engrav LH	2000	J Burn CareRehabil2000，23，6：	1
19	Strategies to inhibit tumor associated integrin receptors:rationale for dual and multi-antagonists显示文摘	Sheldrake HM Patterson LH	2014	J Med Chem2014，57，15：	1
20	Involvement of NADPH:cytochrome P450 reductase in the activation of indoloquinone EO9 to free radical and DNA damaging species 显示文摘	Bailey SM Lewis AD Patterson LH	2001	Biochem Pharmacol2001，62，4：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示